SYNERMORE

Owners

Goods & Services

Biological products, namely, monoclonal antibodies, recombinant proteins for the treatment of oncology, infectious diseases and immune disorders, and diagnostic reagents for medical purposes; biological preparations for medical purposes, namely, biological preparations for the treatment of cancers, infectious diseases, and immunological disorders; biological preparations for use in biotechnology, namely, biological preparations for the treatment of cancers, infectious diseases, and immunological disorders for medical purposes; medicinal preparations for the treatment of cancers, infectious diseases, and immunological disorders; medicines for human purposes, namely, medicines for the treatment of cancers, infectious diseases, and immunological disorders; pharmaceutical preparations for the treatment of cancers, infectious diseases, and immunological disorders; pharmaceuticals for human purposes, namely, pharmaceutical preparations for the treatment of cancers, infectious diseases, and immunological disorders; Biological products, namely, recombinant proteins for medical purposes and vaccines

Biological research and analysis; biotechnology research and analysis; pharmaceutical and biotechnology research and analysis services; product research and development; scientific testing, research and development services in the field of biotechnology and pharmaceutical sciences; industrial testing, research and development services in the field of biotechnology and pharmaceutical sciences